Iqvia Holdings Inc (IQV) CFO Sells $1,219,325.00 in Stock

Iqvia Holdings Inc (NYSE:IQV) CFO Michael R. Mcdonnell sold 9,500 shares of Iqvia stock in a transaction that occurred on Monday, December 3rd. The shares were sold at an average price of $128.35, for a total value of $1,219,325.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Shares of NYSE:IQV opened at $117.98 on Friday. Iqvia Holdings Inc has a 12 month low of $91.57 and a 12 month high of $135.48. The company has a market cap of $24.64 billion, a P/E ratio of 27.06, a PEG ratio of 1.77 and a beta of 0.81. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 1.41.

Iqvia (NYSE:IQV) last announced its earnings results on Monday, October 22nd. The medical research company reported $1.42 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.39 by $0.03. Iqvia had a return on equity of 13.69% and a net margin of 12.29%. The firm had revenue of $2.59 billion for the quarter, compared to analysts’ expectations of $2.58 billion. The company’s revenue was up 5.2% on a year-over-year basis. As a group, analysts anticipate that Iqvia Holdings Inc will post 5.13 earnings per share for the current fiscal year.

A number of institutional investors have recently bought and sold shares of IQV. Cutler Group LP grew its position in Iqvia by 173.3% in the second quarter. Cutler Group LP now owns 1,100 shares of the medical research company’s stock worth $109,000 after buying an additional 2,600 shares during the last quarter. Fort L.P. purchased a new position in Iqvia during the 2nd quarter worth approximately $118,000. Hamilton Lane Advisors LLC purchased a new position in Iqvia during the 3rd quarter worth approximately $121,000. Point72 Hong Kong Ltd grew its position in Iqvia by 2,115.9% during the 3rd quarter. Point72 Hong Kong Ltd now owns 975 shares of the medical research company’s stock worth $126,000 after purchasing an additional 931 shares in the last quarter. Finally, Quad Cities Investment Group LLC purchased a new position in Iqvia during the 2nd quarter worth approximately $140,000. Hedge funds and other institutional investors own 89.33% of the company’s stock.

A number of research firms have recently weighed in on IQV. Zacks Investment Research raised Iqvia from a “hold” rating to a “buy” rating and set a $142.00 price target on the stock in a report on Tuesday, October 23rd. Morgan Stanley lifted their price target on Iqvia from $130.00 to $145.00 and gave the company an “overweight” rating in a report on Monday, December 3rd. Piper Jaffray Companies lifted their price target on Iqvia to $131.00 and gave the company a “neutral” rating in a report on Tuesday, October 23rd. Wells Fargo & Co lifted their price target on Iqvia from $120.00 to $140.00 and gave the company an “outperform” rating in a report on Monday, August 13th. Finally, Barclays lifted their price target on Iqvia from $130.00 to $140.00 and gave the company an “overweight” rating in a report on Tuesday, October 23rd. Five analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $134.41.

TRADEMARK VIOLATION WARNING: “Iqvia Holdings Inc (IQV) CFO Sells $1,219,325.00 in Stock” was posted by Transcript Daily and is the property of of Transcript Daily. If you are viewing this article on another website, it was stolen and republished in violation of US & international copyright and trademark laws. The original version of this article can be read at https://transcriptdaily.com/2018/12/08/iqvia-holdings-inc-iqv-cfo-sells-1219325-00-in-stock.html.

Iqvia Company Profile

IQVIA Holdings Inc provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offers a range of cloud-based applications and related implementation, real-world insights, and reference information services; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.

Recommended Story: Discount Rate

Insider Buying and Selling by Quarter for Iqvia (NYSE:IQV)

Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply